Orbimed Advisors - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 102 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$6,854,000
-22.8%
2,928,9000.0%0.13%
-21.1%
Q2 2022$8,875,000
-54.3%
2,928,900
+2.4%
0.16%
-48.9%
Q1 2022$19,419,000
-18.7%
2,859,9000.0%0.32%
+2.6%
Q4 2021$23,880,000
+21.0%
2,859,900
+7.7%
0.31%
+41.5%
Q3 2021$19,731,000
+35.1%
2,655,600
+23.7%
0.22%
+46.6%
Q2 2021$14,602,000
-22.0%
2,147,400
+17.8%
0.15%
-15.4%
Q1 2021$18,728,0001,823,6000.18%
Other shareholders

There were no reported owners of JOUNCE THERAPEUTICS INC in Q2 2022.

NameSharesValueWeighting ↓
View complete list of JOUNCE THERAPEUTICS INC shareholders